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Methods: Nested-PCR was used to amplify the HBV S gene and
the PCR products were sequenced directly or sequenced after
cloning, the sequences of ‘a’ epitope were then analyzed by
sequence alignment.
Results: Direct sequencing of PCR products showed that there
was one amino acid (AA) residue in ‘a’ epitope less conserved
region emerged polymorphism in each of all 4 HBV infected
patients with both positive HBsAg and HBsAb markers. Clone
sequencing showed that, the AA residue 126 of ‘a’ epitope in
patient 1 could be Thr, Ile and Ser, the AA residue 134 could be
Phe and Ser; the AA residue 126 in patient 2 could be Ala and
Thr, and patient 3 could be Ile and Asn; AA polymorphism was not
found in patient 4.
Conclusions: Mixture virus may exist in HBV infected patients
positive for HBsAg and HBsAb; the polymorphism of HBV quasi-
species ‘a’ epitope sequence should be one of the reasons caused
both HBsAg and HBsAb positive in HBV infected patients.
PP-096 A retrospective study on risk factors of HBV and
HCV in Esfahan, Iran
Mohammadali Zia*,1, Maryam Rouholamin2, Mostafa Banitaba3.
1Islamic Azad University, Khorasgan Branch; 2Payam-e-Noor
University of Esfahan, Vazvan Center; 3Islamic Azad University,
Naein Branch
Background: The Hepatitis viruses, a heterogenous group of
viruses with a tropism for the liver, are the major cause of viral
hepatitis. HBV and HCV are among the most important agents of
viral hepatitis. These viruses are spread parenterally by blood or
needles, by sexual contact and perinatally and etc.
Methods: 254 patients include 163 HBV and 91 HCV were studied
in this research. This study was carried out using recorded infor-
mation in ﬁle of patients in Tropical and Infectious Research Cen-
ter in Esfahan, and information was extracted from these ﬁles.
Results: The history of:
– surgery: HBV: 71 (28% of all patients) - HCV: 48 (18.9% of all
patients)
– blood transmission: HBV: 15 (6.1% of all patients) - HCV: 16
(6.2% of all patients)
– contact with hepatitis patient: HBV: 36 (14.2% of all patients)
- HCV: 15 (6.1% of all patients)
– accident: HBV: 23 (9% of all patients) - HCV: 20 (7.9% of all
patients)
– tattooing: HBV: 30 (11.8% of all patients) - HCV: 7 (2.75% of all
patients)
– cupping: HBV: 22 (8.66% of all patients) - HCV: 6 (2.4% of all
patients)
– sexual contact: HBV: 21 (8.3% of all patients) - HCV: 1 (0.39%
of all patients)
– renal dialysis: HBV and HCV: 0
Conclusion: It seems that the above mentioned risk factors are
very important in epidemiology of Hepatitis. Therefore efﬁcient
education to population and patients to control and prevention
of disease is necessary.
PP-097 Role of hepatitis B virus genotypes, BCP,
precore/core and X gene mutations and the risk
of hepatocellular carcinoma
Mohammad Asim*,1,2, Sunil Kumar Polipalli 2, Nargis Begum1,2,
Istaq Ahmed1,2, Luqman A. Khan1, S.A. Husain1,
L. Thayumanavan3, P. Kar2. 1Jamia Millia Islamia; 2Maulana
Azad Medical college; 3Madurai Medical College
Objectives: We aimed to characterize mutations of HBV genome
involving X gene, basal core promoter (BCP), and Precore/core
regions and also deﬁne HBV genotypes in patients of HCC from
India.
Methods: HBV genotypes and mutations were determined in 150
HCC and 136 chronic liver disease patients without HCC. All HBV
DNA positive cases were subjected to mutational analysis using
SSCP and genotyping by RFLP.
Results: Amongst 150 HCC patients, 79.4% and 20.6% had geno-
type D and A, respectively. The prevalence of genotype D was
signiﬁcantly higher in HCC patients compared with controls
(p=0.03). The T1484, TT1504, T1653, C1705, C1740, C/G1753,
T1762/A1764, A1896 and G1914 mutations were frequent in HCC
cases. The prevalence of the TT1504 mutation in the X gene,
the V1753 and T1762/A1764 mutations in BCP region and G1914
mutation in core gene were signiﬁcantly higher in the HCC group
compared to controls (48% vs 7%, 44% vs 7%, 70% vs 33% and 41%
vs 6.7%, respectively). Also, T1653 (58% vs 14%) mutation was
signiﬁcantly higher for HCC cases. Multivariate analyses showed
that the TT1504, 1653T, C1705, 1753V, and A1762T G1764A mu-
tations and patient age signiﬁcantly increased the risk of HCC
development. Also HCC had lower levels of serum albumin and
platelet count, but higher values of ALP, AST, ALT, Bilirubin and
AFP compared to controls (P<0.001).
Conclusion: HBV genotype D and the exclusively found preva-
lence of certain mutations detected in those with HBV-related
carcinoma nevertheless indicate a degree of association with
disease progression in Indian patients.
PP-098 Resolved hepatitis B virus infection is associated
with poor prognosis in patients with primary
biliary cirrhosis
Fu-kui Zhang*,1, Ying Zhang1, Jun-yong Zhang2, Xue Li 1,
Ji-dong Jia1, Bao-en Wang1. 1Liver Research Center, Beijing
Friendship Hospital, Capital Medical University, Beijing, China;
2Department of Gastroenterology, Shandong Provincial Hospital,
Shandong University, Ji’nan, China
Objective: To study the prevalence of resolved hepatitis B virus
(HBV) infection in patients with primary biliary cirrhosis (PBC)
and whether the resolved infection is associated with much poor
prognosis.
Methods: Sixty PBC patients with negative serum HBsAg were
further measured for other serum HBV infection markers, in-
cluding anti-HBs, HBeAg, HBeAb, HBcAb and HBV DNA. Patients
with resolved HBV infection were termed as serum HBcAb pos-
itive (±anti-HBs±HBeAb), HBsAg negative and HBV DNA unde-
tectable. The severity of the disease including the occurrence
of hypoalbuminemia and/or jaundice, complications of decom-
pensated cirrhosis/portal hypertension such as ascites, hepatic
encephalopathy, upper gastrointestinal variceal bleeding or the
occurrence of hepatocellular carcinoma was compared between
patients with and without resolved HBV infection.
Results: There were 25 patients (41.7%, 58.9±11.3 yr) with
resolved HBV infection and 35 patients (58.3%, 57.8±11.5 yr)
without resolved HBV infection. Complications of decompen-
sated cirrhosis/portal hypertension or the occurrence of HCC
were more frequently occurred in PBC patients with resolved
HBV infection than patients without resolved HBV infection (72%
vs. 37.14%, P<0.01).
Conclusion: Resolved HBV infection was common in Chinese PBC
patients and may be related with much poor prognosis.
Acknowledgement: The study was supported in part by a grant
from Beijing Municipal Science & Technology Commission, “Bei-
jing Nova Program 2006 B54” to Fukui Zhang.
PP-099 Hepatitis B surface antigen mutation Thr to Met
at position 118 leads to antigenicity change and
causes some blood screening kits failure
Yonglin Yang*,1,2, Bo Meng1, Zhuhu Huang2. 1NanJing Red Cross
Blood Center; 2JiangSu Province Hospital Infectious Department
Background: We found a new point mutation A to T in the HBsAg
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gene which caused amino acid to change from Thr to Met at
position aa118 and researched the effects of this mutation on
blood HBsAg screening test.
Methods: HBsAg Gene, which was ampliﬁed by PCR, was cloned
and sequenced, then mutational amino acids were recovered
the wild type at aa117 or/and aa118 position. By insertion of
HBsAg Genes, expressing vectors were constructed and transient
expressions were committed in 293T cells. Suspensions of cell
culture were collected and tested by the panel which contained
ten kinds of HBsAg testing kits provided by companies.
Result: The proﬁle of results tested by Panel were similar be-
tween express suspension of mutation HBsAg gene and donation
serum and most of kits but two failed. But the proﬁle was sig-
niﬁcant difference compared with normal quality control serum.
When mutation was recovered at 117 position, the proﬁle of re-
sults did not change. But mutation was recovered at 118 position,
the proﬁle of results changed, and all kits can effetely test this
HBsAg.
Conclusion:Mutation of HBsAg at 118 position which was changed
from T to M leaded to failure tests by most of kits.
PP-100 Induction of effective anti-HBV speciﬁc T cellular
responses with dendritic cells that modiﬁed by a
recombinant adenovirus vector expressing HBsAg
and CTLA-4 ScFv
Guoping Peng*,1, Cheng Zhou1, Wei Wu1, Hangping Yao1,
Jianming Qiu2, Feng Chen1, Haihong Zhu1, Zhi Chen1. 1National
Key Laboratory of Infectious Diseases, Institute of Infectious
Diseases, First Afﬁliated Hospital, Medical college, Zhejiang
University; 2Institute of Immunology, Zhejiang University
Objectives: To investigate the mechanism and evaluate the ther-
apeutic potential of Ad-S-ScFv transduced DCs in HBV transgenic
mice.
Methods: The ScFv of CTLA-4 was ligated and the recombinant
Ad-S and Ad-S-ScFv were constructed. DCs were transfected with
rAd (Ad-S-ScFv, Ad-S, etc), and HBV-Tg mice were randomly as-
signed to receive different rAd-transduced DCs twice at 3-week
intervals. The HBV speciﬁc IFN-γ+ CD8+ T cells proportion, the
HBsAg-speciﬁc T cellular proliferation and cytotoxic activity of
splenocytes were measured. The serum HBV markers and ALT
levels, the histology and the expression of HBcAg, HBsAg in
tissue samples of liver were also assessed. The expression and
phosphorlation level for the key components of the intracellular
signal pathway of MAPK and PI3K/Akt were detected.
Results: Compared with either DC/Ad-S or DNA immunization,
DC/Ad-S-ScFv can induce much stronger type I immune responses
and HBV-speciﬁc CTLs, and more signiﬁcantly reduce the titer
of serum HBsAg and HBV DNA, and also reduced the expression
of HBcAg and HBsAg in the liver of HBV-Tg mice. The phospho-
rlation expression of Erk1,2 in the liver tissue of DC/Ad-S-ScFv
immunized mice were signiﬁcant increased, but not for the the
PI3K/Akt signal protein.
Conclusion: Ad-S-ScFv transduced DCs may be a promising candi-
date for a CTL-based vaccine for chronic HBV infection, and the
combination with other antiviral strategy could probably acquire
the complete clearance of HBV DNA.
PP-101 Pattern of hepatitis B ‘e’ antigen (HBeAg) in
hepatitis B surface antigen (HBsAg) conﬁrmed
positive cases
Rabindra Nepal*,1, Dhundi Raj Sharma2. 1National Reference
Laboratory; 2Yeti Health Science Academy
Objective: The aim of this study was to explore the pattern
of HBeAg status in HBsAg true positive cases attending National
Reference Laboratory of Nepal.
Materials and Methods: Secondary data were collected by record
review. Serum specimens conﬁrmed for HBsAg positive cases
(n=512), by neutralization method using bioKit, Spain, were sub-
jected to semi-automatic enzyme immunoassay (EIA) GB, Taiwan
for the detection of HBeAg during the period of November 2006
to February 2009. Qualitative results were calculated by cut-off
formula provided in the kit insert and the produced data were
analyzed.
Results: Of the true HBsAg positive (n=512) cases, 76.17% (n=390)
were males and 23.83% (n=122) were females. Data showed that
29.49% (n=151) cases were found to be positive for HBeAg,
among which 31.28% (n=122) were males and 23.77% (n=29) were
females. Age wise distribution of HBeAg seropositivity showed
71.52% (n=108) cases were in the age group 21–50 years, the
most active and productive age group in Nepal.
Conclusion: Such higher prevalence of hepatitis B virus infection
in its actively multiplying phase poses a problem of greater
transmission rate in the communities. As males are more mobile
than females in Nepal our communities are exposed to more risk
of getting hepatitis B virus infection.
Similarly, HBeAg positive mothers may give birth to babies with
HBsAg positive status who ultimately become chronic carrier of
hepatitis B virus.
PP-102 The study of the CD4+CD25+treg induced by
human plasmacytoid dendritic cells from chronic
hepatitis B in vitro
Jun Hong*. Renmin Hospital of Wuhan University
Background: This study was undertaken to investigate whether
PDCs are involved in the generation of a higher proportion of
CD4+CD25+ Treg cells in chronic HBV infection compared with
healthy people.
Methods: The amount, phenotype, and function of Treg in CD4+
T cells primed by PDC from 46 chronic HBV patients, 25 healthy
controls, and 10 individuals with a resolved HBV infection were
studied by the ways of ﬂow cytometry, RT-PCR, ELISA and prolif-
eration assay.
Results: CD4+T cells primed by PDC from chronic HBV patient
were more effective than CD4+ T cells primed by PDC from
healthy controls and resolved HBV patients in suppressing the
HBcAg-speciﬁc proliferation and the interferon production. The
IL-10 and TGF-β1 could be also detectable in the supernatants
of PDC-primed CD4+ T cells. A higher percentage of Treg, de-
ﬁned as CD4, CD25, CD45RO, and CTLA-4-positive cells, was
detected within the population of CD4+ T cells primed by PDC
from chronic HBV patients compared with healthy controls and
individuals with a resolved HBV infection. Accordingly, CD25+Treg
from PDC-primed CD4+ T cells displayed a high Fox P3 messenger
RNA level. Depleting CD4+CD25+ Treg from CD4+ T cells primed by
PDC from chronic HBV patients, healthy volunteers and resolved
HBV patients made PDC-primed CD4+ T to lose the capability in
suppressing HBV-speciﬁc T-cell.
Conclusion: PDCs from the patients with chronic HBV infection
induce the generation of a higher proportion of CD4+CD25+ Treg
compared with the healthy peoples.
PP-103 Abnormal expression of TGF-β1 and IGF-II
associated with HBV replication in human
hepatoma tissues
Dengfu Yao*, Jing Qian, Shanshan Li, Yinzhu Bian. Research
Center of Clinical Medicine, Afﬁliated Hospital of Nantong
University, Nantong, China
Background: The abnormality of many growth factor expressions
involved in the formation and development of HCC, and asscosi-
ated with the alteration of gene methylation status. However,
their molecular mechanism and expression rule remains not too
clear. In the present study, we investigated the relationship
